• Search

Discovery Stems From Here   

Find your tools for building human cell-based models & screening assays

Welcome to Axol Bioscience

YOUR HUMAN CELL CULTURE SPECIALISTS

We provide highly validated human iPSC-derived cells and primary cells from healthy donors and patients of specific disease backgrounds, together with optimized media and growth supplements. Axol aims to develop the best human cell biology research tools to advance medical research and drug discovery. Combining our passion for science with quality, innovation and customer service, we deliver robust and reliable products that our customers need to advance their research faster.

Latest News

  • Introduction of MEA screening services for human iPSC-derived cells

    Axol Bioscience today announced the expansion of its service offering, with the introduction of multi-electrode array (MEA) screening for human induced pluripotent stem cell (hiPSC)-derived cells. The new services have been developed to support pre-clinical research by optimizing hiPSC-derived cell culture, while providing high-quality electrophysiological data acquisition and analysis from physiologically relevant human cell models.

  • Axol Bioscience appoints Liam Taylor as Chief Executive Officer

    Cambridge, UK, 26 August 2020: Axol Bioscience, a biotechnology company specializing in the use of stem cell technology to manufacture disease relevant cell based assay systems to the drug discovery industry, today announced the appointment of Liam Taylor as CEO. Liam will guide the growth of the Company, and will focus on maximizing the potential of the team, and its iPSC (induced pluripotent stem cell) technologies, products and services.

  • Major success for MESO-BRAIN partners will lead to breakthrough technology for developing new brain models


  • Neuroimmunology Drug Development (NIDD) 2019

    Our Booth #760
    Our Workshop (find out more)
    Our Poster (find out more)

  • Axol Bioscience launch human iPSC-derived Microglia

    Cambridge, UK – (6th December 2018) – Axol Bioscience, the human cell culture specialist, is launching a new line of Human induced Pluripotent Stem Cells (iPSC)-derived Microglia for the consistent and reproducible study of neuroglia and their involvement in neurodegenerative diseases, including Alzheimer’s disease, multiple sclerosis and Parkinson’s disease.